coIMMUNE Revenue and Competitors
Estimated Revenue & Valuation
- coIMMUNE's estimated annual revenue is currently $3.7M per year.
- coIMMUNE's estimated revenue per employee is $77,520
Employee Data
- coIMMUNE has 48 Employees.
- coIMMUNE grew their employee count by -2% last year.
coIMMUNE's People
Name | Title | Email/Phone |
---|---|---|
1 | Staff Scientist | Reveal Email/Phone |
2 | CQV Specialist II | Reveal Email/Phone |
3 | Stability Program Coordinator | Reveal Email/Phone |
4 | Quality Associate II | Reveal Email/Phone |
5 | QC Stability Coordinator | Reveal Email/Phone |
6 | Associate Researcher | Reveal Email/Phone |
coIMMUNE Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.4M | 42 | 0% | N/A | N/A |
#2 | $928.5M | 6502 | 0% | N/A | N/A |
#3 | $19.6M | 175 | -1% | N/A | N/A |
#4 | $5.4M | 68 | 8% | N/A | N/A |
#5 | $0.6M | 10 | -33% | N/A | N/A |
#6 | $19.4M | 177 | 11% | $1.8M | N/A |
#7 | $3.1M | 38 | 0% | N/A | N/A |
#8 | $17.6M | 157 | 8% | N/A | N/A |
#9 | $21.4M | 177 | 35% | N/A | N/A |
#10 | $11.3M | 103 | 10% | N/A | N/A |
What Is coIMMUNE?
CoImmune Inc. is a US company based in Durham North Carolina that was founded in 2019 based on its expertise in the development and manufacture of cell-based therapeutics to treat unmet medical needs including cancer, autoimmune and inflammatory diseases.
keywords:N/AN/A
Total Funding
48
Number of Employees
$3.7M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
coIMMUNE News
2020-11-10 - CoImmune Closes $45 Million Series A Financing
DURHAM, N.C., Nov. 10, 2020 (GLOBE NEWSWIRE) -- CoImmune, Inc., an immuno-oncology company developing cell-based therapeutics to treat unmet medical needs in blood-borne and solid tumor indications, today announced the closing of a $45M Series A financing. CoImmune will use the proceeds from the ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.3M | 48 | -20% | $2.8M |
#2 | $6.9M | 48 | 4% | N/A |
#3 | $7.5M | 48 | -2% | N/A |
#4 | $12.9M | 49 | 40% | N/A |
#5 | $10.6M | 49 | 7% | N/A |